The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of lapatinib as a component of neoadjuvant therapy for HER2+ operable breast cancer: NSABP protocol B-41.
Andre Robidoux
Consultant or Advisory Role - GlaxoSmithKline (U)
Honoraria - GlaxoSmithKline; Roche
Research Funding - GlaxoSmithKline; Roche
Gong Tang
No relevant relationships to disclose
Priya Rastogi
No relevant relationships to disclose
Charles E. Geyer
No relevant relationships to disclose
Catherine A. Azar
No relevant relationships to disclose
James Norman Atkins
No relevant relationships to disclose
Louis Fehrenbacher
No relevant relationships to disclose
Harry Douglas Bear
Honoraria - Roche/Genentech
Luis Baez-Diaz
No relevant relationships to disclose
J. Phillip Kuebler
No relevant relationships to disclose
Richard G. Margolese
No relevant relationships to disclose
William Blair Farrar
No relevant relationships to disclose
Adam Brufsky
No relevant relationships to disclose
Henry R. Shibata
No relevant relationships to disclose
Hanna Bandos
No relevant relationships to disclose
Soonmyung Paik
Research Funding - GlaxoSmithKline
Joseph P. Costantino
No relevant relationships to disclose
Sandra M. Swain
Consultant or Advisory Role - Genentech (U); Nektar (U); Novartis (U); Roche (U); Sanofi (U)
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer; Roche/Genentech; Sanofi
Other Remuneration - Sanofi
Eleftherios P. Mamounas
Consultant or Advisory Role - Roche/Genentech
Norman Wolmark
No relevant relationships to disclose